291 related articles for article (PubMed ID: 21707826)
1. Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Pawate S; Wang L; Song Y; Sriram S
J Neuroimaging; 2012 Apr; 22(2):137-44. PubMed ID: 21707826
[TBL] [Abstract][Full Text] [Related]
2. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
Bakshi R; Benedict RH; Bermel RA; Caruthers SD; Puli SR; Tjoa CW; Fabiano AJ; Jacobs L
Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
[TBL] [Abstract][Full Text] [Related]
3. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Khalid F; Tauhid S; Chua AS; Healy BC; Stankiewicz JM; Weiner HL; Bakshi R
Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245
[TBL] [Abstract][Full Text] [Related]
6. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
Chu R; Hurwitz S; Tauhid S; Bakshi R
BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
[TBL] [Abstract][Full Text] [Related]
7. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis.
Zhang Y; Zabad R; Wei X; Metz L; Hill M; Mitchell J
Mult Scler; 2007 Aug; 13(7):880-3. PubMed ID: 17468444
[TBL] [Abstract][Full Text] [Related]
8. Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study.
Blazejewska AI; Al-Radaideh AM; Wharton S; Lim SY; Bowtell RW; Constantinescu CS; Gowland PA
J Magn Reson Imaging; 2015 Apr; 41(4):1065-70. PubMed ID: 24841344
[TBL] [Abstract][Full Text] [Related]
9. Natalizumab therapy for highly active pediatric multiple sclerosis.
Kornek B; Aboul-Enein F; Rostasy K; Milos RI; Steiner I; Penzien J; Hellwig K; Pitarokoili K; Storm van's Gravesande K; Karenfort M; Blaschek A; Meyer A; Seidl R; Debelic D; Vass K; Prayer D; Kristoferitsch W; Bayas A
JAMA Neurol; 2013 Apr; 70(4):469-75. PubMed ID: 23420110
[TBL] [Abstract][Full Text] [Related]
10. The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis.
Cohen JA; Krishnan AV; Goodman AD; Potts J; Wang P; Havrdova E; Polman C; Rudick RA
JAMA Neurol; 2014 Nov; 71(11):1386-93. PubMed ID: 25178496
[TBL] [Abstract][Full Text] [Related]
11. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
[TBL] [Abstract][Full Text] [Related]
12. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.
Tjoa CW; Benedict RH; Weinstock-Guttman B; Fabiano AJ; Bakshi R
J Neurol Sci; 2005 Jul; 234(1-2):17-24. PubMed ID: 15993137
[TBL] [Abstract][Full Text] [Related]
13. Differential changes in deep and cortical gray matters of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
Zhou F; Zee CS; Gong H; Shiroishi M; Li J
J Comput Assist Tomogr; 2010; 34(3):431-6. PubMed ID: 20498549
[TBL] [Abstract][Full Text] [Related]
14. MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.
Fox RJ; Cree BA; De Sèze J; Gold R; Hartung HP; Jeffery D; Kappos L; Kaufman M; Montalbán X; Weinstock-Guttman B; Anderson B; Natarajan A; Ticho B; Duda P;
Neurology; 2014 Apr; 82(17):1491-8. PubMed ID: 24682966
[TBL] [Abstract][Full Text] [Related]
15. Age and sex related differences in subcortical brain iron concentrations among healthy adults.
Persson N; Wu J; Zhang Q; Liu T; Shen J; Bao R; Ni M; Liu T; Wang Y; Spincemaille P
Neuroimage; 2015 Nov; 122():385-98. PubMed ID: 26216277
[TBL] [Abstract][Full Text] [Related]
16. Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).
Chen X; Zeng C; Luo T; Ouyang Y; Lv F; Rumzan R; Wang Z; Li Q; Wang J; Hou H; Huang F; Li Y
Eur J Radiol; 2012 Apr; 81(4):e633-9. PubMed ID: 22280874
[TBL] [Abstract][Full Text] [Related]
17. Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
Rinaldi F; Calabrese M; Seppi D; Puthenparampil M; Perini P; Gallo P
Mult Scler; 2012 Dec; 18(12):1760-7. PubMed ID: 22570359
[TBL] [Abstract][Full Text] [Related]
18. Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.
Prosperini L; Giannì C; Leonardi L; De Giglio L; Borriello G; Galgani S; Pozzilli C; Gasperini C
Mult Scler; 2012 Jan; 18(1):64-71. PubMed ID: 21828195
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; Saccà F; Baroncini D; Comi G; Trojano M;
Brain; 2015 Nov; 138(Pt 11):3275-86. PubMed ID: 26362907
[TBL] [Abstract][Full Text] [Related]
20. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
